All stocks today
71229 stocks real-time data.
All stocks today

Stock quotes

Stock market live

Historical stock prices

Stocks market capitalization

Dividend stocks

Stock earnings

Stock revenue

Stock ratings. Where to invest?

Sino Biopharmaceutical Limited revenue reports

Sino Biopharmaceutical Limited financial reports, Sino Biopharmaceutical Limited annual revenue in 2020. When does Sino Biopharmaceutical Limited report revenue?
Add to widgets
Added to widgets

Sino Biopharmaceutical Limited total revenue, net income and dynamics of changes in US dollar today

The dynamics of Sino Biopharmaceutical Limited net revenue increased by 474 178 000 $ from the last reporting period. Sino Biopharmaceutical Limited net income is now 811 168 000 $. The dynamics of Sino Biopharmaceutical Limited net income went up. The change was 223 521 000 $. The financial graph of Sino Biopharmaceutical Limited shows the values and changes of such indicators: total assets, net income, net revenue. Sino Biopharmaceutical Limited financial report on the graph shows the dynamics of assets. Sino Biopharmaceutical Limited total revenue on the graph is shown in yellow.

Report date Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and Change (%)
Comparing current quartal report this year to quartal report last year.
30/09/2019 6 793 461 000 $ +13.13 % ↑ 811 168 000 $ -2.923 % ↓
30/06/2019 6 319 283 000 $ +24.58 % ↑ 587 647 000 $ -1.164 % ↓
31/03/2019 6 208 026 000 $ - 856 702 000 $ -
31/12/2018 5 158 421 000 $ - 6 845 089 000 $ -
30/09/2018 6 004 931 000 $ - 835 589 000 $ -
30/06/2018 5 072 618 000 $ - 594 567 000 $ -
Show:
to

Sino Biopharmaceutical Limited financial report charts

Dates of Sino Biopharmaceutical Limited finance reports: 30/06/2018, 30/06/2019, 30/09/2019. The dates of the financial statements are determined by the accounting rules. The latest financial report of Sino Biopharmaceutical Limited is available online for such a date - 30/09/2019. Gross profit Sino Biopharmaceutical Limited is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit Sino Biopharmaceutical Limited is 5 474 422 000 $

Sino Biopharmaceutical Limited quarterly report dates

Cost of revenue Sino Biopharmaceutical Limited is the total cost of producing and distributing of products and services of a company. Cost of revenue Sino Biopharmaceutical Limited is 1 319 039 000 $ Total revenue Sino Biopharmaceutical Limited refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue Sino Biopharmaceutical Limited is 6 793 461 000 $ Operating income Sino Biopharmaceutical Limited is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Sino Biopharmaceutical Limited is 1 702 206 000 $

Net income Sino Biopharmaceutical Limited is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Sino Biopharmaceutical Limited is 811 168 000 $ Current assets Sino Biopharmaceutical Limited is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Sino Biopharmaceutical Limited is 21 856 565 000 $ Total assets Sino Biopharmaceutical Limited refers to the total amount of assets owned by a person or entity. Total assets Sino Biopharmaceutical Limited is 53 774 095 000 $

30/09/2019 30/06/2019 31/03/2019 31/12/2018 30/09/2018 30/06/2018
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
5 474 422 000 $ 5 080 077 000 $ 4 995 086 000 $ 4 048 592 000 $ 4 776 329 000 $ 4 156 334 000 $
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
1 319 039 000 $ 1 239 206 000 $ 1 212 940 000 $ 1 109 829 000 $ 1 228 602 000 $ 916 284 000 $
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
6 793 461 000 $ 6 319 283 000 $ 6 208 026 000 $ 5 158 421 000 $ 6 004 931 000 $ 5 072 618 000 $
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
- - - - - -
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
1 702 206 000 $ 1 313 545 000 $ 1 126 889 000 $ 195 772 000 $ 1 834 791 000 $ 1 180 056 000 $
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
811 168 000 $ 587 647 000 $ 856 702 000 $ 6 845 089 000 $ 835 589 000 $ 594 567 000 $
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
- - - - - -
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
5 091 255 000 $ 5 005 738 000 $ 5 081 137 000 $ 4 962 649 000 $ 4 170 140 000 $ 3 892 562 000 $
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
21 856 565 000 $ 21 865 171 000 $ 20 175 292 000 $ 18 538 125 000 $ 18 572 025 000 $ 16 880 121 000 $
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
53 774 095 000 $ 53 471 187 000 $ 51 439 141 000 $ 49 780 208 000 $ 37 293 487 000 $ 34 985 598 000 $
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
6 135 649 000 $ 7 181 548 000 $ 6 190 308 000 $ 6 676 042 000 $ 6 300 784 000 $ 5 539 552 000 $
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
10 085 603 000 $ 10 142 750 000 $ 10 911 291 000 $ 9 668 621 000 $ 10 503 416 000 $ 7 689 554 000 $
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
- - - - - -
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
14 639 706 000 $ 14 659 822 000 $ 13 475 611 000 $ 12 230 684 000 $ 11 885 073 000 $ 10 688 842 000 $
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
27.22 % 27.42 % 26.20 % 24.57 % 31.87 % 30.55 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
30 576 102 000 $ 29 924 114 000 $ 29 673 993 000 $ 29 212 838 000 $ 20 721 629 000 $ 20 293 762 000 $
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
- - - - - -

Last revenue report of Sino Biopharmaceutical Limited was 30/09/2019. According to last financial report total revenue in Sino Biopharmaceutical Limited was 6 793 461 000 US dollar and changed by +13.13% since last year. Net income in Sino Biopharmaceutical Limited was 811 168 000 $ in last quartal, net income changes to -2.923%.

Current cash Sino Biopharmaceutical Limited - the sum of all of the cash a company has on the date of report. Current cash Sino Biopharmaceutical Limited is 6 135 649 000 $ Current debt Sino Biopharmaceutical Limited is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital. Current debt Sino Biopharmaceutical Limited is 10 085 603 000 $ Total debt Sino Biopharmaceutical Limited is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year. Total debt Sino Biopharmaceutical Limited is 14 639 706 000 $

Sino Biopharmaceutical Limited stocks data

Sino Biopharmaceutical Limited financials